These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16354125)

  • 1. Defining the opportunity for pharmacogenetic intervention in primary care.
    Grice GR; Seaton TL; Woodland AM; McLeod HL
    Pharmacogenomics; 2006 Jan; 7(1):61-5. PubMed ID: 16354125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerns and beliefs about medicines and inappropriate medications: An Internet-based survey on risk factors for self-reported adverse drug events among older adults.
    Shiyanbola OO; Farris KB
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):245-57. PubMed ID: 20624614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug events in ambulatory care.
    Gandhi TK; Weingart SN; Borus J; Seger AC; Peterson J; Burdick E; Seger DL; Shu K; Federico F; Leape LL; Bates DW
    N Engl J Med; 2003 Apr; 348(16):1556-64. PubMed ID: 12700376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature and frequency of exchanges on medications during primary care encounters.
    Richard C; Lussier MT
    Patient Educ Couns; 2006 Dec; 64(1-3):207-16. PubMed ID: 16781108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized medication assessment and planning: optimizing medication use in older adults in the primary care setting.
    Roth MT; Ivey JL; Esserman DA; Crisp G; Kurz J; Weinberger M
    Pharmacotherapy; 2013 Aug; 33(8):787-97. PubMed ID: 23722438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary care visit duration and quality: does good care take longer?
    Chen LM; Farwell WR; Jha AK
    Arch Intern Med; 2009 Nov; 169(20):1866-72. PubMed ID: 19901138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported medication symptoms in primary care.
    Weingart SN; Gandhi TK; Seger AC; Seger DL; Borus J; Burdick E; Leape LL; Bates DW
    Arch Intern Med; 2005 Jan; 165(2):234-40. PubMed ID: 15668373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacogenetics and prediction of side effects of drugs].
    Harrak M; Khabbal Y; Amarti A; El Hassouni M; Ouldim K
    Ann Biol Clin (Paris); 2014; 72(4):405-12. PubMed ID: 25119798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of health literacy with medication knowledge, adherence, and adverse drug events among elderly veterans.
    Mosher HJ; Lund BC; Kripalani S; Kaboli PJ
    J Health Commun; 2012; 17 Suppl 3():241-51. PubMed ID: 23030573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is primary care ready for pharmacogenetics?
    Voora D; Gage BF
    Pharmacogenomics; 2006 Jan; 7(1):1-3. PubMed ID: 16354118
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents.
    Nguyen JK; Fouts MM; Kotabe SE; Lo E
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):36-41. PubMed ID: 16730619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future.
    Alfirevic A; Pirmohamed M
    Pharmacogenomics; 2010 Apr; 11(4):497-9. PubMed ID: 20350129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study.
    Hutchison LC; Jones SK; West DS; Wei JY
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):144-53. PubMed ID: 16860261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews.
    Fillit HM; Futterman R; Orland BI; Chim T; Susnow L; Picariello GP; Scheye EC; Spoeri RK; Roglieri JL; Warburton SW
    Am J Manag Care; 1999 May; 5(5):587-94. PubMed ID: 10537865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.